Comparison of the Efficacy of S-1 Plus Oxaliplatin or Capecitabine Plus Oxaliplatin for Six and Eight Chemotherapy Cycles as Adjuvant Chemotherapy in Patients With Stage II-III Gastric Cancer After D2 Resection

Comparison of the Efficacy of S-1 Plus Oxaliplatin or Capecitabine Plus Oxaliplatin for Six and Eight Chemotherapy Cycles as Adjuvant Chemotherapy in Patients With Stage II-III Gastric Cancer After D2 Resection

ObjectiveTo compare the efficacy of adjuvant chemotherapy with six or eight cycles of S-1 plus oxaliplatin (SOX) or Capecitabine plus oxaliplatin (XELOX) after D2 resection of GC.Design and participantsWe collected 470 cases of patients with TNM stage II and III GC who underwent D2 gastrectomy in th...

Full description

Bibliographic Details
Main Authors: Yuanyuan Yu, Zicheng Zhang, Qianhao Meng, Yue Ma, Xiaona Fan, Jie Sun, Guangyu Wang
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-05-01
Series:Frontiers in Oncology
Subjects:
adjuvant chemotherapy
gastric cancer
chemotherapy cycles
S-1 plus oxaliplatin
capecitabine plus oxaliplatin
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2021.684627/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2021.684627/full

Similar Items